上皮性卵巢癌三种化疗方案疗效对比  

The contrast of different chemotherapeutic effect of epithelial ovarian cancer

作　　者：万诗[1] 黄冬梅[1] 

机构地区：[1]郑州大学第二附属医院妇产科,郑州450014

出　　处：《中国现代医药杂志》2011年第7期37-38,共2页Modern Medicine Journal of China

摘　　要：目的探讨增加其他化疗药物或者使用新一代的化疗药物能否增加紫杉醇联合卡铂(TC)方案对于上皮性卵巢癌的化疗疗效。方法回顾性分析我科2008年1月至2011年1月初次诊断为上皮性卵巢癌并接受化疗的25例患者的临床资料。结果 3种化疗方案的化疗反应率、毒性反应均无显著性差异,P>0.05。结论增加其他化疗药物或者使用多西他赛联合卡铂或奥沙利铂并不能增加紫杉醇联合卡铂(TC)方案对于上皮性卵巢癌的化疗疗效。Objective To explore whether adding chemotherapy drugs or new generation of chemotherapy drugs could improve the curative effects of paclitaxel plus carboplatin scheme chemotherapy or not.Methods Retrospective analysis the clinical data of 25 patients,complied with a standard selection for the epithelial ovarian cancer,who were selected in the second affiliated hospital of Zhengzhou university from Jan 2008 to Jan 2011.Results There were no significant differences among the three groups for chemotherapy response rate and toxicity reaction（P0.05）.Conclusion Adding other chemotherapy drugs or docetaxel plus carboplatin or oxaliplatin could not increase the curative effect of paclitaxel plus carboplatin scheme chemotherapy.

关 键 词：上皮性 卵巢癌 化疗 

分 类 号：R737.31[医药卫生—肿瘤]